A Phase Ii Study (Nct01883323) Evaluating the Infusion of Autologous Tumor-Infiltrating Lymphocytes (Til) and Low-Dose Interleukin-2 (Il-2) Therapy Following Non-Myeloablative Lymphodepletion Using Cyclophosphamide and Fludarabine in Patients with Metastatic Melanoma

Annals of Oncology - Tập 25 - Trang iv391 - 2014
L.T. Khoja1, L. Nguyen2, L. Wang3, B. Zhang1, J. Nie2, P.H. Yen2, M. Pnaik2, M. Powis2, N. Franke1, M. Crump1, D. Hogg1, A.M. Joshua1, P. Ohashie2, M.O. Butler2
1Medical Oncology, Princess Margaret Hospital, Toronto, ON, CANADA
2Immune Therapy Programme, Princess Margaret Hospital, Toronto, ON, CANADA
3Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada